Clinical Trial

Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy

Study acronym: PREG-Q10
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled clinical trial aims to evaluate the effectiveness of adjunctive coenzyme Q10 and probiotic supplementation (Limosilactobacillus reuteri Prodentis®) in improving periodontal health in pregnant women undergoing non-surgical periodontal therapy. Forty participants will be randomly assigned to two groups: the test group will receive professional oral hygiene every three months along with a coenzyme Q10-based toothpaste and daily probiotic supplementation; the control group will follow the same protocol without probiotics. The primary outcome is the reduction of the Plaque Index (PI), while secondary outcomes include Bleeding on Probing (BoP), Probing Pocket Depth (PPD), Clinical Attachment Level (CAL), gingival inflammation (MGI, PMGI), plaque distribution (PCR%, API), and gingival recession (R). The study duration is 6 months. The goal is to assess whether this combined therapy can promote a balanced oral microbiota and enhance periodontal health during pregnancy.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-11; most recent amendment 2026-02-19.
Status change: Not Yet Recruiting → Recruiting 2025-08-17
Trial Details
NCT Number NCT07029360
Lead Sponsor University of Pavia
Conditions Pregnancy, Periodontal Disease, Gingivitis, Dental Plaque, Probiotics, Coenzyme Q10, Microbiota
Enrollment 40 participants
Start Date 2025-07-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-20